Case Report
Rapid Resolution of Chronic Back Pain with Magnesium Glycinate in a Pediatric Patient
Christine Lamontagne1*, John A Sewell2, Régis Vaillancourt2 and Cyrus Kuhzarani3,4 | |
1Children’s Hospital of Eastern Ontario | |
2School of Pharmacy, University of Waterloo | |
3Pure Lab Vitamins Inc. | |
4Desjardins Pharmacy | |
Corresponding Author : | Christine Lamontagne Director of Acute and Chronic Pain Services Department of Anesthesiology CHEO, Assistant Professor of Anesthesia University of Ottawa, Canada Tel: +1 313 577 3231 Fax: 613-738-4815 E-mail: clamontagne@cheo.on.ca |
Received January 02, 2012; Accepted January 10, 2012; Published January 16, 2012 | |
Citation: Lamontagne C, Sewell JA, Vaillancourt R, Kuhzarani C (2012) Rapid Resolution of Chronic Back Pain with Magnesium Glycinate in a Pediatric Patient. J Pain Relief 1:101. doi: 10.4172/2167-0846.1000101 | |
Copyright: © 2012 Lamontagne C, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
Abstract
A 10-year-old male presented to a pediatric complex chronic pain clinic with debilitating back pain associated with vertebral compression fractures secondary to corticosteroid-induced osteoporosis. The pain failed to respond to routine analgesics and zoledronic acid. Oral magnesium glycinate and topical magnesium/guaifenesin cream were initiated upon presentation to the clinic, and resulted in a rapid and sustained reduction in pain, increased flexibility and improved quality of life. Magnesium is a known N-methyl-D-aspartate receptor antagonist, and should be considered in the management of chronic pain. The roles of glycine and guaifenesin in the management of chronic pain are not well-understood, but may warrant further examination in the context of chronic pain.